Ken Griffin Brainstorm Cell Therapeutics Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 40,000 shares of BCLI stock, worth $46,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,000

Previous 50,400 20.63%

Holding current value

$46,800

Previous $28,000 53.57%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.2 $55,576 - $88,921	27,788 Added 211.03%	40,956 $84,000
Q1 2023 May 15, 2023	SELL	$1.43 - $3.3 $4,713 - $10,876	-3,296 Reduced 20.02%	13,168 $43,000
Q4 2022 Feb 14, 2023	SELL	$1.37 - $4.42 $19,923 - $64,280	-14,543 Reduced 46.9%	16,464 $27,000
Q3 2022 Nov 14, 2022	BUY	$2.55 - $4.42 $13,571 - $23,523	5,322 Added 20.72%	31,007 $137,000
Q2 2022 Aug 15, 2022	BUY	$2.71 - $3.6 $4,243 - $5,637	1,566 Added 6.49%	25,685 $70,000
Q1 2022 May 16, 2022	BUY	$2.92 - $4.19 $22,305 - $32,007	7,639 Added 46.35%	24,119 $81,000
Q3 2021 Nov 15, 2021	SELL	$3.14 - $4.09 $108,917 - $141,869	-34,687 Reduced 67.79%	16,480 $54,000
Q2 2021 Aug 16, 2021	BUY	$3.01 - $4.01 $34,955 - $46,568	11,613 Added 29.36%	51,167 $194,000
Q1 2021 May 17, 2021	BUY	$3.46 - $7.88 $94,506 - $215,234	27,314 Added 223.15%	39,554 $151,000
Q4 2019 Feb 14, 2020	SELL	$3.62 - $4.29 $16,557 - $19,622	-4,574 Reduced 27.2%	12,240 $52,000
Q2 2019 Aug 14, 2019	BUY	$3.59 - $4.3 $10,421 - $12,482	2,903 Added 20.87%	16,814 $66,000
Q1 2019 May 15, 2019	BUY	$3.37 - $4.34 $10,258 - $13,210	3,044 Added 28.01%	13,911 $0
Q4 2018 Feb 14, 2019	BUY	$2.98 - $3.9 $32,383 - $42,381	10,867 New	10,867 $38,000
Q1 2018 May 11, 2018	SELL	$3.01 - $3.77 $45,252 - $56,678	-15,034 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$2.96 - $4.42 $698 - $1,043	236 Added 1.59%	15,034 $59,000
Q3 2017 Nov 09, 2017	BUY	$3.98 - $4.36 $58,896 - $64,519	14,798	14,798 $61,000

Others Institutions Holding BCLI

# of Institutions

Shares Held

12.1M

Call Options Held

169K

Put Options Held

30.6K

View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $42.7M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

More about BCLI

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account